{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T22:10:50Z","timestamp":1794003050049,"version":"4.8.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,27]],"date-time":"2022-02-27T00:00:00Z","timestamp":1645920000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81773404"],"award-info":[{"award-number":["81773404"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U1904209"],"award-info":[{"award-number":["U1904209"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.biopha.2022.112768","type":"journal-article","created":{"date-parts":[[2022,3,2]],"date-time":"2022-03-02T11:33:54Z","timestamp":1646220834000},"page":"112768","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"special_numbering":"C","title":["PD-1\/PD-L1 inhibitor ameliorates silica-induced pulmonary fibrosis by maintaining systemic immune homeostasis"],"prefix":"10.1016","volume":"148","author":[{"given":"Youliang","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changfu","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaqian","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonghua","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuedan","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huifang","family":"Si","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wu","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2022.112768_bib1","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1056\/NEJMra1705751","article-title":"Idiopathic pulmonary fibrosis","volume":"378","author":"Lederer","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2022.112768_bib2","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/978-1-4939-7113-8_2","article-title":"The bleomycin model of pulmonary fibrosis","volume":"1627","author":"Liu","year":"2017","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.biopha.2022.112768_bib3","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.chest.2019.03.033","article-title":"Radiation-induced lung injury: assessment and management","volume":"156","author":"Hanania","year":"2019","journal-title":"Chest"},{"key":"10.1016\/j.biopha.2022.112768_bib4","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S2213-2600(20)30225-3","article-title":"Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy.","volume":"8","author":"George","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.biopha.2022.112768_bib5","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1016\/S0140-6736(12)60235-9","article-title":"Silicosis","volume":"379","author":"Leung","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2022.112768_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.ecoenv.2020.110364","article-title":"Silica particles disorganize the polarization of pulmonary macrophages in mice","volume":"193","author":"Zhao","year":"2020","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"10.1016\/j.biopha.2022.112768_bib7","doi-asserted-by":"crossref","first-page":"26108","DOI":"10.1039\/C8RA03970D","article-title":"Dendritic cells trigger imbalance of Th1\/Th2 cells in silica dust exposure rat model via MHC-II, CD80, CD86 and IL-12","volume":"8","author":"Bao","year":"2018","journal-title":"RSC Adv."},{"key":"10.1016\/j.biopha.2022.112768_bib8","doi-asserted-by":"crossref","first-page":"110","DOI":"10.3389\/fimmu.2017.00110","article-title":"IL-10-producing CD1d(hi)CD5(+) regulatory B cells may play a critical role in modulating immune homeostasis in silicosis patients","volume":"8","author":"Chen","year":"2017","journal-title":"Front Immunol."},{"key":"10.1016\/j.biopha.2022.112768_bib9","article-title":"Tregs promote the differentiation of Th17 cells in silica-induced lung fibrosis in mice","volume":"7","author":"Song","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2022.112768_bib10","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.taap.2013.11.012","article-title":"Neutralization of interleukin-17A delays progression of silica-induced lung inflammation and fibrosis in C57BL\/6 mice","volume":"275","author":"Chen","year":"2014","journal-title":"Toxicol. Appl. Pharm."},{"key":"10.1016\/j.biopha.2022.112768_bib11","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.7150\/thno.29682","article-title":"Dioscin alleviates crystalline silica-induced pulmonary inflammation and fibrosis through promoting alveolar macrophage autophagy","volume":"9","author":"Du","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.biopha.2022.112768_bib12","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s13287-018-0846-9","article-title":"Transplantation of adipose-derived mesenchymal stem cells attenuates pulmonary fibrosis of silicosis via anti-inflammatory and anti-apoptosis effects in rats","volume":"9","author":"Chen","year":"2018","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.biopha.2022.112768_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8101547","article-title":"Immune checkpoints as promising targets for the treatment of idiopathic pulmonary fibrosis?","volume":"8","author":"Duitman","year":"2019","journal-title":"J. Clin. Med"},{"key":"10.1016\/j.biopha.2022.112768_bib14","first-page":"2020","article-title":"Nivolumab plus ipilimumab in advanced non-small-cell lung cancer","volume":"381","author":"Hellmann","year":"2019"},{"key":"10.1016\/j.biopha.2022.112768_bib15","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41572-020-0160-6","article-title":"Immune-related adverse events of checkpoint inhibitors","volume":"6","author":"Ramos-Casals","year":"2020","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.biopha.2022.112768_bib16","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aar8356","article-title":"PD-1 up-regulation on CD4(+) T cells promotes pulmonary fibrosis through STAT3-mediated IL-17A and TGF-beta1 production","volume":"10","author":"Celada","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.biopha.2022.112768_bib17","doi-asserted-by":"crossref","first-page":"3733","DOI":"10.4049\/jimmunol.1700059","article-title":"Cutting edge: anti-TIM-3 treatment exacerbates pulmonary inflammation and fibrosis in mice","volume":"199","author":"Isshiki","year":"2017","journal-title":"J. Immunol."},{"key":"10.1016\/j.biopha.2022.112768_bib18","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.ijheh.2011.10.010","article-title":"Genetic polymorphisms and surface expression of CTLA-4 and PD-1 on T cells of silica-exposed workers","volume":"215","author":"Rocha","year":"2012","journal-title":"Int J. Hyg. Environ. Health"},{"key":"10.1016\/j.biopha.2022.112768_bib19","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3389\/fimmu.2016.00097","article-title":"Silica, silicosis, and autoimmunity","volume":"7","author":"Pollard","year":"2016","journal-title":"Front Immunol."},{"key":"10.1016\/j.biopha.2022.112768_bib20","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/978-981-15-3266-5_9","article-title":"Functions of immune checkpoint molecules beyond immune evasion","volume":"1248","author":"Zhang","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.biopha.2022.112768_bib21","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s00262-020-02717-2","article-title":"Varied functions of immune checkpoints during cancer metastasis","volume":"70","author":"Safarzadeh","year":"2021","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.biopha.2022.112768_bib22","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1146\/annurev-pathol-042020-042741","article-title":"Immune checkpoint inhibitors for the treatment of cancer: clinical impact and mechanisms of response and resistance","volume":"16","author":"Bagchi","year":"2021","journal-title":"Annu Rev. Pathol."},{"key":"10.1016\/j.biopha.2022.112768_bib23","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1126\/science.aaa8172","article-title":"The future of immune checkpoint therapy","volume":"348","author":"Sharma","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.biopha.2022.112768_bib24","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1111\/bcp.14316","article-title":"Mechanism-based treatment of cancer with immune checkpoint inhibitor therapies","volume":"86","author":"Abdou","year":"2020","journal-title":"Br. J. Clin. Pharm."},{"key":"10.1016\/j.biopha.2022.112768_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20030593","article-title":"Idiopathic pulmonary fibrosis and lung cancer: mechanisms and molecular targets","volume":"20","author":"Ballester","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2022.112768_bib26","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1038\/s41467-020-16466-4","article-title":"Activation of JUN in fibroblasts promotes pro-fibrotic programme and modulates protective immunity","volume":"11","author":"Cui","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2022.112768_bib27","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.immuni.2018.03.014","article-title":"Regulation and function of the PD-L1 checkpoint","volume":"48","author":"Sun","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.biopha.2022.112768_bib28","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.125326","article-title":"PD-L1 on invasive fibroblasts drives fibrosis in a humanized model of idiopathic pulmonary fibrosis","volume":"4","author":"Geng","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.biopha.2022.112768_bib29","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1165\/rcmb.2017-0326OC","article-title":"PD-1\/PD-L1 pathway mediates the alleviation of pulmonary fibrosis by human mesenchymal stem cells in humanized mice","volume":"58","author":"Ni","year":"2018","journal-title":"Am. J. Respir. Cell Mol. Biol."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222001561?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222001561?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T06:32:41Z","timestamp":1781764361000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332222001561"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":29,"alternative-id":["S0753332222001561"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2022.112768","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PD-1\/PD-L1 inhibitor ameliorates silica-induced pulmonary fibrosis by maintaining systemic immune homeostasis","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2022.112768","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"112768"}}